The 3D printing boom in the last several years has sweeping implications for the future of pharmaceuticals and medical devices. With the enormous potential 3D printed products have in the life sciences, there are equally as many unknowns regarding risk and liability throughout the supply chain.
Join Bowman and Brooke and Berkley Life Sciences for a complimentary one hour webinar on the current regulatory landscape for 3D printed pharmaceuticals and devices. Our experienced panel will discuss recent developments in the regulatory world of 3D printed materials and the types of risk mitigation you can take to safeguard and defend your products.
Topic: 3D Printed Pharmaceuticals and Devices—Assessing, Managing and Insuring Against Risk
Date: Thursday,November 10, 2016
Time: 11 am PT/ 1 pm CT / 2 pm ET
Lindsey Adams-Hess, Associate, Bowman and Brooke
Jenny Covington, Partner, Bowman and Brooke
Sonia Weiss, AVP & Senior Life Science Risk Management Specialist, Berkley Life Sciences
Cindy Khin, Life Sciences Casualty Resolution Director, Berkley Life Sciences